Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Product News
Texas Center for Proton Therapy Selects RayStation for Treatment Planning
Tuesday, July 07, 2015
With plans to open in late 2015, the next-generation proton center will use RayStation® exclusively for all patient planning.

Planmed Launches the New Planmed Clarity™ 3D System
Friday, July 03, 2015
Improved mammography diagnostics with Digital Breast Tomosynthesis.

Functional Annotation Tools for Geneious Bioinformatics Platform
Thursday, July 02, 2015
BioBam and Biomatters are very happy to announce the release of an integrated plugin on the Geneious platform for molecular biologists to comprehensively functionally annotate and interpret novel sequences.

Validive® at the MASCC/ISOO International Symposium
Wednesday, July 01, 2015
Oral presentation of Phase II trial results and meeting with its International Advisory Board.

Multiplicom Launches a New Test for the Diagnosis of CLL
Tuesday, June 30, 2015
New CLL MASTR™ Plus kit delivers a simple, fast and affordable genetic test to labs.

Biocartis’ KRAS Mutation Test Receives CE-IVD Marking
Wednesday, June 24, 2015
Biocartis’ Idylla™ KRAS Mutation Test is the first fully automated IVD KRAS Test to match novel guidelines - capable of detecting an extended panel of 21 KRAS mutations with high sensitivity.

Optimized ChIP Protocols for qPCR and Sequencing
Thursday, June 18, 2015
Protocols developed using proprietary solid state chromatin immunoprecipitation technology.

Highly Efficient ChIP Assay Kit for FFPE Samples
Thursday, June 18, 2015
New Chromatrap® FFPE ChIP kit provides sufficient DNA to perform library preps for ChIP-seq assays.

ITL and Oncascan Developing Instrument for New Cancer Test
Thursday, June 18, 2015
Integrated Technologies Limited has signed a development contract with in-vitro diagnostics start-up Oncascan Limited for a new cancer test.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2569
Scientific News
Personalized Screening for Ovarian Cancer
With 60% of women diagnosed with ovarian cancer dying within five years of diagnosis there has been considerable efforts to try to detect the disease at an earlier stage.
p53 Checks Centriole Numbers to Prevent Harmful Cell Divisions
Scientists at Johns Hopkins say they have learned that most cells will not divide without centrioles, and they found out why.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Gene Therapy for Cystic Fibrosis Shows Encouraging Trial Results
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial.
In Blinding Eye Disease, Trash-Collecting Cells Go Awry, Accelerate Damage
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
How the Mammoth Got its Wool
Evolutionary change in a gene reconstructed in the lab from the woolly mammoth was part of a suite of adaptations that allowed the mammoth to survive in harsh arctic environments, according to new research.
Brain Cells Switch Epigenetic Gears Throughout Life
Research finds that histone turnover regulates how genes in the brain are turned on and off in response to various stimuli, thereby allowing neurons to form new synaptic connections.
More Accurate Prediction on Prognosis in Multiple Myeloma (Bone Marrow Cancer)
Test of Dutch-based SkylineDx gives patients better insight in their chances and enables clinicians to adjust their treatment.
NuGEN Scientists Screen 400+ Genes for Fusion Events in Single Assay
Breakthrough proves efficacy of new sample preparation method that could accelerate cancer research and development of treatments and diagnostic tests.
Team Identifies Gene Responsible for Some Cases of Male Infertility
In the most severe form of male infertility, men do not make any measurable levels of sperm. This condition, called azoospermia, affects approximately 1 percent of the male population and is responsible for about a sixth of cases of male infertility.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters